Back to Search
Start Over
Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?
- Source :
- Leukemia & lymphoma, Vol. 63, no. 3, p. 743-746 (2022)
- Publication Year :
- 2022
-
Abstract
- SARS-CoV-2 vaccines offered great hope in controlling the worldwide COVID-19 pandemic. At present, SARS-CoV-2 vaccines have shown excellent efficacy to prevent COVID-19 but immunocompromised patients were left-off most vaccine clinical trials albeit their extreme vulnerability. Indeed, immunosuppression is associated with a higher risk of developing severe COVID-19 with mortality rates over 30% reported in patients with hematologic malignancies (HM). [...]
Details
- Database :
- OAIster
- Journal :
- Leukemia & lymphoma, Vol. 63, no. 3, p. 743-746 (2022)
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1328227932
- Document Type :
- Electronic Resource